India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
The companies will leverage their respective proprietary technology platforms
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
The objective of this study is to evaluate the efficacy of ASC22 (Envafolimab) combined with Chidamide on the viral reservoirs of latently infected cells in HIV patients.
This will give a boost to cost-effective, quality medicines and contribute towards reduction in out of pocket expenditure on healthcare for the citizens
Subscribe To Our Newsletter & Stay Updated
